Compare
Cooper Companies, Inc. vs National Vision Holdings, Inc. vs Staar Surgical Co
| Latest fiscal year | Cooper Companies, Inc. COO | National Vision Holdings, Inc. EYE | Staar Surgical Co STAA |
|---|---|---|---|
| Year ended | 2025-10-31 | 2026-01-03 | 2026-01-02 |
| Revenue | $4.09B | $1.99B | $239.44M |
| Revenue growth (YoY) | +5.1% | +9.0% | -23.7% |
| Gross margin | 65.5% | n/a | 76.2% |
| Operating margin | 16.7% | 3.0% | -38.3% |
| Net margin | 9.2% | 1.5% | -33.6% |
| Net income | $374.90M | $29.60M | -$80.45M |
| EPS (Diluted) | $1.87 | $0.37 | -$1.62 |
| Operating cash flow | $796.10M | $146.29M | -$34.23M |
| Free cash flow | $433.70M | $73.45M | -$40.05M |
| Cash & equivalents | $110.60M | $38.71M | $153.15M |
| Total assets | $12.39B | $1.98B | $451.68M |
| Total liabilities | $4.16B | n/a | $107.49M |
| Shareholders' equity | $8.24B | $869.53M | $344.18M |
| Return on year-end equity | 4.6% | 3.4% | -23.4% |
| Shares outstanding | 195.90M | 79.42M | 49.40M |
Revenue, most recent five fiscal years
| Fiscal year | Cooper Companies, Inc. | National Vision Holdings, Inc. | Staar Surgical Co |
|---|---|---|---|
| Latest | $4.09B Ended 2025-10-31 | $1.99B Ended 2026-01-03 | $239.44M Ended 2026-01-02 |
| 1 year earlier | $3.90B Ended 2024-10-31 | $1.82B Ended 2024-12-28 | $313.90M Ended 2024-12-27 |
| 2 years earlier | $3.59B Ended 2023-10-31 | $1.76B Ended 2023-12-30 | $322.42M Ended 2023-12-29 |
| 3 years earlier | $3.31B Ended 2022-10-31 | $1.64B Ended 2022-12-31 | $239.44M Ended 2022-12-30 |
| 4 years earlier | $2.92B Ended 2021-10-31 | $2.08B Ended 2022-01-01 | $230.47M Ended 2021-12-31 |